LONDON and NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory
LONDON, May 17, 2022 (GLOBE NEWSWIRE) OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), a life sciences company focused on the discovery and development of novel molecules to
LONDON and NEW YORK, Oct. 20, 2021 (GLOBE NEWSWIRE) Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for